Notice NOT-DC-24-015 from the NIH Guide for Grants and Contracts

Notice NOT-DE-24-010 from the NIH Guide for Grants and Contracts

Notice NOT-DE-24-009 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-078 from the NIH Guide for Grants and Contracts

Notice NOT-MD-24-002 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-089 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research.

Notice NOT-CA-24-024 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-105 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for the continued support and advancement of the Mutant Mouse Resource and Research Centers (MMRRC). The MMRRC consortium is expected to facilitate research by identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. A regional network of four MMRRCs and an Informatics, Coordination and Service Center (ICSC) collectively serve the needs of the biomedical research community for transgenic, knockout and other genetically-engineered mutant mice and related biomaterials. MMRRC strains are held to the highest standards to optimize reproducibility of studies and assure scientific rigor and transparency; all submitted strains are thoroughly reviewed and documented and include additional quality control measures. The Program Director/Principal Investigator (PD/PI) of each MMRRC in addition to the major resource activities is required to develop a small high risk, high return, research pilot project that complements the goals and needs of the MMRRC consortium.

Notice NOT-OD-24-052 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-24-006 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for renewal of the NHGRI Technology Development Coordinating Center (TDCC). The TDCC will continue to provide an infrastructure for enhancing and advancing efforts supported by NHGRIs Genome Technology Program. The Centers activities will include facilitating opportunities for new research collaborations to advance technology development and dissemination. The TDCC will also develop outreach strategies and resources to engage the broader biomedical research community and provide an Opportunity Funds Program to support innovative small-scale work.

Notice NOT-OD-24-031 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-105 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-100 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-038 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-101 from the NIH Guide for Grants and Contracts. This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery; and ancillary studies designed to add scientific aims to active studies being conducted within StrokeNet. Successful applicants will collaborate and conduct the study within the NIH StrokeNet. Following peer review, NINDS will prioritize studies among the highest scoring to be conducted in the NIH StrokeNet infrastructure. The NIH StrokeNet National Coordinating Center (NCC) will work with the successful applicant to implement the proposed study efficiently and the National Data Management Center (NDMC) will provide statistical and data management support. The NIH StrokeNet Regional Coordinating Centers (RCCs) and their affiliated clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.

Notice NOT-HL-23-127 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-126 from the NIH Guide for Grants and Contracts

Notice NOT-GM-24-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-076 from the NIH Guide for Grants and Contracts. The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity Announcement (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This Funding Opportunity is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this NOFO include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies that are NOT conducted with specific applications toward processes or products in mind and which also do not meet the clinical trial definition should submit under the appropriate Clinical Trial Not Allowed NOFO .

Funding Opportunity PAR-24-075 from the NIH Guide for Grants and Contracts. The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.